Jürgen Held

Jürgen Held is currently Head of Diagnostic Microbiology at the University Hospital Erlangen, Germany. He is a clinical microbiologist with a special focus on the diagnosis of fungal diseases.
Jürgen Held studied biochemistry and medicine at the Universities of Tübingen and Münster, graduating in 2000 and 2003 respectively. After two years as a resident in internal medicine, he began his training in medical microbiology at the University of Freiburg, Germany, and graduated as a specialist in medical microbiology, virology and infection epidemiology in 2011. He has been a senior physician at the Microbiology Institute of the University Hospital Erlangen since 2014 and Head of Diagnostic Microbiology since 2021. Jürgen Held is also a member of the Antibiotic Stewardship Steering Committee at the University Hospital Erlangen.
Scientifically he focussed on optimising the diagnosis of invasive mycoses. He was the first to introduce the β-D glucan measurement in Germany and since then focussed on the application of fungal biomarkers in clinical routine. Numerous presentations on national and international congresses as well as many publications in renowned journals attest to his scientific work. In 2012 he received an education scholarship from the German-speaking Mycological Society (DMykG) and in 2015 the Diagnostic Prize from the German Society for Hygiene and Microbiology (DGHM). Since 2018, Jürgen Held has been a member of the Board of the Division of Diagnostic and Clinical Microbiology of the German Society for Hygiene and Microbiology (DGHM) and took over the chair in 2022. In 2021 he was congress president of the annual scientific meeting of the German-speaking Mycological Society (DMykG).